Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01620216
Title Validation of an in Vitro Assay to Predict Targeted Therapies for Acute Leukemia Patients
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors OHSU Knight Cancer Institute
Indications

acute lymphoblastic leukemia

acute myeloid leukemia

Therapies

Sunitinib

Dasatinib

Nilotinib

Ponatinib

Sorafenib

Age Groups: adult
Covered Countries USA


No variant requirements are available.